TIVAPRAMIDE

This brand name is authorized in Nigeria.

Active ingredients

The drug TIVAPRAMIDE contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8920	Capsule	LOPERAMIDE 2MG CAPSULES CAP 2 mg 10 X 10	50 RNW-PP-346573 LOPERAMIDE 2MG CAPSULES LOPERAMIDE HYDROCHLORIDE BP 2MG Loperamide Hydrochloride 2mg. List of excipients Sodium starch glycolate, Microcrystalline cellulose, Colloidal anhydrous silica, Lactose monohydrate (Dried), Magnesium stearate, EHG Capsule Size ‘2’ B4-8920 Drugs Imported Products 10x10 Over The Counter (OTC) 9/15/2023 TALLIS PHARMACEUTICAL COMPANY NIG LTD, NIGER ROAD, S/GARI KANO KANO Impulse Pharma PVT. Limited , Plot No. J-201, 202/1, MIDC, Tarapur, Boisar, Tal & Dist.: Palghar-401 506, India, India	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8920